U.S. Markets open in 1 hr 1 min

How Should Investors Feel About Core Laboratories N.V.'s (NYSE:CLB) CEO Pay?

Simply Wall St

David Demshur has been the CEO of Core Laboratories N.V. (NYSE:CLB) since 1994. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. Then we'll look at a snap shot of the business growth. And finally we will reflect on how common stockholders have fared in the last few years, as a secondary measure of performance. This process should give us an idea about how appropriately the CEO is paid.

View our latest analysis for Core Laboratories

How Does David Demshur's Compensation Compare With Similar Sized Companies?

According to our data, Core Laboratories N.V. has a market capitalization of US$1.7b, and pays its CEO total annual compensation worth US$8.9m. (This is based on the year to December 2018). We think total compensation is more important but we note that the CEO salary is lower, at US$1.0m. When we examined a selection of companies with market caps ranging from US$1.0b to US$3.2b, we found the median CEO total compensation was US$4.1m.

Thus we can conclude that David Demshur receives more in total compensation than the median of a group of companies in the same market, and of similar size to Core Laboratories N.V.. However, this doesn't necessarily mean the pay is too high. We can get a better idea of how generous the pay is by looking at the performance of the underlying business.

You can see a visual representation of the CEO compensation at Core Laboratories, below.

NYSE:CLB CEO Compensation, August 23rd 2019

Is Core Laboratories N.V. Growing?

Core Laboratories N.V. has increased its earnings per share (EPS) by an average of 10% a year, over the last three years (using a line of best fit). Its revenue is up 2.2% over last year.

Overall this is a positive result for shareholders, showing that the company has improved in recent years. It's also good to see modest revenue growth, suggesting the underlying business is healthy. You might want to check this free visual report on analyst forecasts for future earnings.

Has Core Laboratories N.V. Been A Good Investment?

Given the total loss of 65% over three years, many shareholders in Core Laboratories N.V. are probably rather dissatisfied, to say the least. So shareholders would probably think the company shouldn't be too generous with CEO compensation.

In Summary...

We examined the amount Core Laboratories N.V. pays its CEO, and compared it to the amount paid by similar sized companies. As discussed above, we discovered that the company pays more than the median of that group.

However we must not forget that the EPS growth has been very strong over three years. However, the returns to investors are far less impressive, over the same period. One might thus conclude that it would be better if the company waited until growth is reflected in the share price, before increasing CEO compensation. Whatever your view on compensation, you might want to check if insiders are buying or selling Core Laboratories shares (free trial).

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.